Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 13, 2019 at 04:03 am EDT
Share
Euro-Med Laboratories Phil., Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was PHP 968.145 million compared to PHP 878.476 million a year ago. Net income was PHP 44.243 million compared to PHP 37.812 million a year ago. Basic earnings per share was PHP 0.01 compared to PHP 0.01 a year ago. For the half year, sales was PHP 1,842.192 million compared to PHP 1,682.154 million a year ago. Net income was PHP 104.319 million compared to PHP 94.881 million a year ago. Basic earnings per share was PHP 0.03 compared to PHP 0.02 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
